The Department of Oncology, including the Division of Cancer Medicine and the MRC Oxford Institute for Radiation Oncology, has an established world-leading graduate training programme for science graduates and clinical research fellows under the leadership of Professor Mark Middleton.
It is one of the largest departments in the University of Oxford’s Medical Sciences Division. It houses over 400 staff and graduate students, both clinical and non-clinical, and brings together research and clinical groups from across Oxford who are based at the Old Road Campus Research Building (ORCRB), the Radiobiology Research Institute (RRI), the Weatherall Institute for Molecular Medicine (WIMM) and the NHS Cancer and Haematology Centre.
The Department of Oncology offers promising graduates a broad range of multidisciplinary and translational cancer research projects. As a result, its graduates come from a wide range of scientific backgrounds, including biology, medicine, engineering, mathematics, chemistry and physics and the department prides itself on supporting and training the next generation of world leaders in cancer research to ensure its research continues over the long term.
The department ethos is to improve treatment of cancer patients by harnessing Oxford University’s scientific research prowess and translating this into an impactful benefit to cancer patients through our own clinical trials. Working together to achieve this aim, we have renowned experts alongside cutting-edge scientists that collaborate across the university to understand the biology of cancer and how to best adopt new therapeutic strategies in medical and clinical oncology. Our individual research groups can be found here[LINK] and investigate cancer-focused aspects of DNA regulation (damage and repair, replication), cell and tissue biology (tumour microenvironment) and Immunity (immunoncology, vaccines and virotherapy) with the intent of developing strategies in the clinic together with industrial partners.